Skip to content

Biodesix, Inc. BDSX Debt Issuance Costs Included In Accounts Payable And Other Accrued Liabilities

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept bdsx:DebtIssuanceCostsIncludedInAccountsPayableAndOtherAccruedLiabilities.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s debt issuance costs included in accounts payable and other accrued liabilities.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s debt issuance costs included in accounts payable and other accrued liabilities?
Biodesix, Inc. (BDSX) reported debt issuance costs included in accounts payable and other accrued liabilities of $8K in Q1 2025.
How has Biodesix, Inc.'s debt issuance costs included in accounts payable and other accrued liabilities changed year-over-year?
Biodesix, Inc.'s debt issuance costs included in accounts payable and other accrued liabilities decreased by 38.5% year-over-year, from $13K to $8K.